ARCHIVES

Bills Would Give FDA Authority to Approve Generic Biotech Drugs.

This article is from The Cancer Letter archive.

Vol. 33 No. 06 | February 16, 2007

Download PDF Visit The Full Archive

Related Articles

Emory, Children’s Strengthen Ties

May 25, 2001

ODAC Calls For Tougher Standards For Accelerated Approval In Oncology

February 11, 2011

NCI Seen Shifting Away From Comprehensive Center Emphasis Toward Encouraging Clinical Excellence

April 30, 1976

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

ACCC Annual Meeting Expands to 4 Days, One On Cancer Control

January 15, 1982

FASEB Seeks $27.3B For NIH, Increases For Research, Training, And Infrastructure.

February 1, 2002